Altimmune Inc (ALT)
8.405
+0.36
(+4.41%)
USD |
NASDAQ |
Nov 21, 16:00
8.39
-0.02
(-0.18%)
After-Hours: 06:17
Altimmune Shareholders Equity (Quarterly): 133.38M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 133.38M |
June 30, 2024 | 152.53M |
March 31, 2024 | 172.94M |
December 31, 2023 | 194.10M |
September 30, 2023 | 150.40M |
June 30, 2023 | 167.71M |
March 31, 2023 | 167.73M |
December 31, 2022 | 185.29M |
September 30, 2022 | 205.03M |
June 30, 2022 | 194.54M |
March 31, 2022 | 184.87M |
December 31, 2021 | 199.14M |
September 30, 2021 | 209.26M |
June 30, 2021 | 241.28M |
March 31, 2021 | 246.44M |
December 31, 2020 | 225.88M |
September 30, 2020 | 199.71M |
June 30, 2020 | 79.52M |
March 31, 2020 | 41.90M |
December 31, 2019 | 45.52M |
September 30, 2019 | 49.38M |
June 30, 2019 | 56.22M |
March 31, 2019 | 59.32M |
December 31, 2018 | 48.31M |
September 30, 2018 | 39.68M |
Date | Value |
---|---|
June 30, 2018 | 36.32M |
March 31, 2018 | 46.49M |
December 31, 2017 | 48.68M |
September 30, 2017 | 57.07M |
June 30, 2017 | 75.98M |
March 31, 2017 | 18.05M |
December 31, 2016 | 32.21M |
September 30, 2016 | 136.38M |
June 30, 2016 | 24.25M |
March 31, 2016 | 15.63M |
December 31, 2015 | 16.65M |
September 30, 2015 | 17.67M |
June 30, 2015 | 18.34M |
March 31, 2015 | 20.02M |
December 31, 2014 | 18.27M |
September 30, 2014 | 18.11M |
June 30, 2014 | 10.86M |
March 31, 2014 | 8.325M |
December 31, 2013 | 7.336M |
September 30, 2013 | 11.35M |
June 30, 2013 | 13.22M |
March 31, 2013 | 9.943M |
December 31, 2012 | 11.67M |
September 30, 2012 | 12.55M |
June 30, 2012 | 13.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
41.90M
Minimum
Mar 2020
246.44M
Maximum
Mar 2021
169.86M
Average
185.08M
Median
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 14.24B |
Viking Therapeutics Inc | 911.45M |
Amgen Inc | 7.527B |
Avid Bioservices Inc | 58.64M |
NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 147.86M |
Total Liabilities (Quarterly) | 14.49M |
Current Ratio | 16.87 |